Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human Cadherin 10 ELISA Kit (AC2646)
Cat.#: ASET-1235
Specifications
Description Human Cadherin 10 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human Cadherin 10 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.045 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 1.5-24 ng/mL Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1185 Human NMDAR2A ELISA Kit (AC2596) Quantitative inquiry ASET-1130 Mouse Leptin ELISA Kit (AC2541) Quantitative inquiry ASET-1470 Human GCH1 ELISA Kit (AC2881) Quantitative inquiry ASET-2207 Human CHRNA2 ELISA Kit (AC3618) Quantitative inquiry ASET-2395 Mouse Nrg2 ELISA Kit (AC3806) Quantitative inquiry ASET-2348 Rat BDNF ELISA Kit (AC3759) Quantitative inquiry ASET-2195 Human PTPRS ELISA Kit (AC3606) Quantitative inquiry ASET-1712 Human GnRHR ELISA Kit (AC3123) Quantitative inquiry ASET-1906 Human LPPR4 ELISA Kit (AC3317) Quantitative inquiry ASET-1428 Sheep Myelin Basic Protein ELISA Kit (AC2839) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket